Novavax (NVAX) Stock

NVAX Watch

Novavax

$8.09

$0.01 0.12%

1 Min 5 Min 15 Min Hourly Daily Weekly

Assets Gross Profit Revenue Earnings Expenses

Chart Sentiment News Fundamentals About

Long

@long_gam...

301 Trades 54.2% Winrate 22.1% Avg Gain Avg Gain 83.8% S&P Beat

Shorted NVAX Shares

6d ago • Swung • Bearish

down -13.71% At 7.11, Now 8.09

Given the disconnect between the positive developments in the malaria vaccine and NVAX's poor stock performance, I believe it’s wise to short NVAX. Th... Read More

0 0

Degenerate

@wsb

1035 Trades 47.3% Winrate 13.6% Avg Gain Avg Gain 359.1% S&P Beat

Bought NVAX Shares

46d ago • Swung • Bullish

down -7.27% At 13.61, Exited 12.62

I'm really optimistic about NVAX, especially after their deal with Sanofi which should drive revenue and growth. With a 30% short interest, I'm antici... Read More

Exited 38d ago

0 0

Biostonks69

@9n6g89hh...

10 Trades 70.0% Winrate 2.8% Avg Gain Avg Gain -0.7% S&P Beat

Bought NVAX Shares

96d ago • Invested • Bullish

down -37.74% At 12.98, Now 8.09

Riding the wave of the smallpox fear. Company has good financials with $1B cash on hand and in a good position to receive government funding, grants, ... Read More

1 0

Degenerate

@wsb

1035 Trades 47.3% Winrate 13.6% Avg Gain Avg Gain 359.1% S&P Beat

Bought NVAX Shares

96d ago • Invested • Bullish

down -44.12% At 12.92, Exited 7.22

Novavax is well-positioned to capitalize on the monkeypox outbreak with its proven vaccine platform, strong financial position, and potential for gove... Read More

Exited 6d ago

1 1